AI-Assisted Carotid Ultrasound for Nonexpert Use in Primary Care Cardiovascular Prevention: User-Centered Iterative Development Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

User-Centered Iterative Development of AI-Guided Carotid Ultrasound for Cardiovascular Prevention in Primary Care by Nonexperts

  • By

  • Anna Sjöström

  • Christer Grönlund

  • Karolina Jonzén

  • Patrik Wennberg

  • Åsa Hörnsten

  • Thorbjörn Lundberg

  • Anni-Maria Pulkki-Brännström

  • Luisa Ebeling

  • Albin Dahlin Almevall

  • October 8, 2026

Share

  • 1

    Carotid ultrasound is operator-dependent, and in Sweden highly trained biomedical scientists generally perform examinations in hospitals.

  • 2

    AI-assisted ultrasound may provide automated guidance and real-time image analysis, potentially enabling nonexperts to perform clinically relevant examinations.

  • 3

    Automated carotid intima-media thickness measurements have been reproducible when obtained by novice operators, whereas manual plaque detection has substantial interobserver variability.

  • 4

    Evidence remains limited on integrating AI-assisted plaque detection into routine workflows and on its use by nonexpert operators.

  • 5

    The article examines user-centered iterative development of AI-guided carotid ultrasound for cardiovascular prevention in primary care by nonexperts.

Original Source(s)

AI-Assisted Carotid Ultrasound for Nonexpert Use in Primary Care Cardiovascular Prevention: User-Centered Iterative Development Study

  • by Anna Sjöström, Christer Grönlund, Karolina Jonzén, Patrik Wennberg, Åsa Hörnsten, Thorbjörn Lundberg, Anni-Maria Pulkki-Brännström, Luisa Ebeling, Albin Dahlin Almevall

  • October 8, 2026

Related Content

Stage-Based Model of User Engagement Patterns in an Online Health Community for Cardiovascular Disease Management: Qualitative Interview Study

Bringing Cardiac Rehabilitation Closer to Patients

Machine Learning–Driven Risk Prediction Model in Transthyretin Amyloid Cardiomyopathy